Life Science Firms Partner on AI-Powered Autonomous Laboratory Systems
1 report, 1 independent
Updated Oct 8
AI-generated briefing. Brind wrote this from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Beckman Coulter, Abcam, Cytiva, and Molecular Devices are contributing technology to autonomous laboratory systems. Danaher announced plans to launch its first AI-powered autonomous lab in early 2027. This facility, located at Abcam's headquarters in Cambridge, UK, will use AI and robotics to accelerate the development of custom antibodies and molecular tools.
Why it matters
The trend involves pharmaceutical research labs moving toward automated, hybrid environments that combine AI and robotics. These closed-loop systems are designed to independently plan, execute, and analyze experiments with minimal human intervention.
Who's involved
- Beckman Coulter Life SciencesSupplying technology for autonomous laboratory systems.
- AbcamHeadquarters location for the new AI-powered autonomous lab.
- CytivaContributing technology to autonomous laboratory systems.
- Molecular DevicesContributing core technologies to Danaher's new AI-powered autonomous lab.
- Danaher CorporationLaunching the AI-powered autonomous lab using its technologies.
Keep exploring
The entities involved
-
Beckman Coulter Life Sciences
Nothing else this week.
-
Abcam
UK business
Nothing else this week.
-
Cytiva
biotech company
Nothing else this week.